4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-053010
Director sold 4,000 shares at an average $65.59 ($262,360)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cantley Lewis Clayton Jr. Director | 2017-09-13 | Sale | −1,000 | $65.47 | $65,470 | 86,394 | D |
| Cantley Lewis Clayton Jr. Director | 2017-09-13 | Sale | −1,000 | $65.47 | $65,470 | 86,434 | I |
| Cantley Lewis Clayton Jr. Director | 2017-09-14 | Sale | −1,000 | $65.71 | $65,710 | 85,394 | D |
| Cantley Lewis Clayton Jr. Director | 2017-09-14 | Sale | −1,000 | $65.71 | $65,710 | 85,434 | I |
| Open-market sales · 4,000 sh · avg $65.59 · $262,360 | |||||||
Loading xslF345X03/doc4.xml…